You searched for "device"

1294 results found

Early vs late activation of cochlear implant device

Device activation after cochlear implant surgery was typically performed after wound healing, and varies anytime from three to four weeks after surgery. Nowadays, activation is performed as early as two to three days after surgery. The authors evaluated the effect...

Tinnitus treatment device from concept to commercialisation

Innovation in the field of healthcare is fraught with nearly insurmountable challenges. Bringing a novel product to the market requires a new (patentable) idea that can be reduced to practice, manufactured at scale, and can pass all regulatory barriers. In...

Come and see the UV Smart D60 disinfection device!

The UV Smart D60 is a CE marked (MDR Class IIa) disinfection device specifically designed for channel-less ENT endoscopes and TEE probes.

Outcomes at three years post-implantation of the Bonebridge device

This is a MED-EL-funded study of the hearing outcomes and complication rates of the Bonebridge active transcutaneous bone conduction implant (BCI). The authors have declared no conflict of interest. Follow-up occurred at intervals for 36 months post-implantation in all 57...

Surgical anatomy for central auditory device implantation

This cadaveric study by researchers in the USA and Japan examined the cerebellopontine angles with the aid of the surgical microscope and 45o endoscope via the retrosigmoid and translabyrinthine approach. Using fibre dissection technique, the ascending auditory pathways between the...

Lenire® Tinnitus Treatment Device

Lenire is a bimodal neuromodulation device that combines custom audio and mild pulses to the tongue to drive long-term relief from tinnitus. Lenire is proven across three large-scale clinical trials to be a safe, effective and highly recommended tinnitus treatment....

Supporting parents in improving their child’s hearing device use time

On the topic of supporting parents with improving their child’s hearing device time, The Hearing Journal recommends sharing a video from Hearing First (video provided online by Hear Jour; produced by www.hearingfirst.org) and provides a unique printable resource for parents...

Direct-to-consumer hearing devices: a need to combine cosmetic appeal with device capabilities

How safe and desirable are direct-to-consumer amplification devices? A team has put a range of devices through their paces and compared them to a standard NHS hearing device. Why do most individuals who would benefit from hearing aids not try...

Neuromod launches Lenire tinnitus treatment device to tinnitus sufferers in the UK

Neuromod Devices has launched its Lenire tinnitus treatment device in the United Kingdom, where it is estimated that seven million people suffer from tinnitus.

Breakthrough tinnitus device Lenire available in three new clinics in Spain

Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.

UK clinics providing Lenire tinnitus treatment device double in latest expansion

Neuromod Devices, the medical device company that specialises in tinnitus treatment, has announced they are partnering with four UK clinics to expand the availability of Lenire®, the clinically proven tinnitus treatment device. Tinnitus, which is commonly known as “ringing in...

Development of a new negative-pressure ventilatory support device: Exovent

The pandemic has driven innovation in ways that we have not seen for many decades. Intensive care medicine and ENT have been at the forefront of these advances, and our good friends David Howard (never one to put his feet...